Desvenlafaxine Succinate Tablet, Extended Release while Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Desvenlafaxine Succinate Tablet, Extended Release and its risk associated with lactation. We will also discuss the usage of Desvenlafaxine Succinate Tablet, Extended Release and some common side effects associated with Desvenlafaxine Succinate Tablet, Extended Release.

What is Desvenlafaxine Succinate Tablet, Extended Release used for?


Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)]. Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) (1).

Is using Desvenlafaxine Succinate Tablet, Extended Release unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Desvenlafaxine Succinate Tablet, Extended Release safe for breastfeeding
Desvenlafaxine is the only one ingredient used in manufacturing of Desvenlafaxine Succinate Tablet, Extended Release, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Desvenlafaxine it is safe to use Desvenlafaxine Succinate Tablet, Extended Release while lactating. We suggest you to check further details below about Desvenlafaxine usage in breastfeeding.

Desvenlafaxine Succinate Tablet, Extended Release Breastfeeding Analsys


Desvenlafaxine while Breastfeeding

Safe

CAS Number: 93413-62-8

It is a reuptake-inhibitor of Serotonin and Norepinephrine, and active metabolite of Venlafaxine. It is excreted in low amount into breast milk. The amount detected in the infant's plasma is in the range of 2% - 6% respective to the amount found in the mother's plasma that is considered to be much lower than that found when the mother takes Venlafaxine. Not relevant side-effects have been found in such infants.


Desvenlafaxine Succinate Tablet, Extended Release Breastfeeding Analsys - 2


Desvenlafaxine while Breastfeeding

CAS Number: 93413-62-8

Modest doses of desvenlafaxine are excreted into breastmilk, but serum drug levels of breastfed infants are less than 10% of simultaneous maternal levels. Total drug exposure of breastfed infants is about half of that experienced by breastfed infants whose mothers are taking venlafaxine.[1] Breastfed infants, especially newborn or preterm infants, should be monitored for excessive sedation and adequate weight gain if this drug is used during lactation, possibly including measurement of serum levels to rule out toxicity if there is a concern. With the related drug venlafaxine, newborn infants of mothers who took the drug during pregnancy sometimes experienced poor neonatal adaptation as seen with other antidepressants such as SSRIs or SNRIs. Similar effects may occur with desvenlafaxine.



What should I do if I am breastfeeding mother and I am already exposed to Desvenlafaxine Succinate Tablet, Extended Release?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Desvenlafaxine Succinate Tablet, Extended Release and have used it then do not panic as Desvenlafaxine Succinate Tablet, Extended Release is mostly safe in breastfeeding and should not cause any harm to your baby.


My health care provider has asked me to use Desvenlafaxine Succinate Tablet, Extended Release, what to do?

Definitely, Desvenlafaxine Succinate Tablet, Extended Release is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Desvenlafaxine Succinate Tablet, Extended Release, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Desvenlafaxine Succinate Tablet, Extended Release


Who can I talk to if I have questions about usage of Desvenlafaxine Succinate Tablet, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week